Durham, NC, United States of America

Andrew E Balber

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2022

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew E Balber

Introduction

Andrew E Balber is a notable inventor based in Durham, NC (US), recognized for his significant contributions to the field of medical science. He holds a total of 4 patents, showcasing his dedication to advancing healthcare solutions. His work primarily focuses on treatments for demyelinating conditions and the utilization of stem cell populations.

Latest Patents

Among his latest patents, one notable invention is titled "Compositions and methods for the treatment of demyelinating conditions." This patent provides compositions that include the DUOC-01 cell product and an anti-inflammatory agent, aimed at treating demyelinating conditions. Another significant patent is "Stem cell populations and methods of use," which relates to isolating stem cell populations and methods for repairing and regenerating tissues. This invention also includes methods for screening agents that promote the growth and differentiation of stem cells.

Career Highlights

Throughout his career, Andrew has worked with prominent organizations such as Aldagen, Inc. and Duke University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Andrew has collaborated with notable colleagues, including Tracy Gentry and Sandra J Foster. These partnerships have further enriched his research and innovation efforts.

Conclusion

In summary, Andrew E Balber's innovative work and patents have made a significant impact in the medical field, particularly in the treatment of demyelinating conditions and stem cell research. His contributions continue to inspire advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…